EFFECTIVENESS OF SOFOSBUVIR/VELPATASVIR (SOF/VEL) IN PATIENTS WITH CHRONIC HCV INFECTION AND PSYCHIATRIC DISORDERS: REAL-WORLD CARE MANAGEMENT FROM 6 COUNTRIES / Milligan, S1; Barrett, L2; Teti, E³; Garcia-Retortillo, M⁴; Wedemeyer, H⁵; Fraser, C6; Morano, L⁷; Rodriguez-Tajes, S⁸; Acosta-Lopez, S⁹; O’Loan, J10; Milella, M11; Buti, M12; Guerra Veloz, Mf13; Ramji, A14; Fernandez-Rodriguez, Cm15; Martins Figueiredo, L16; Fenech, M17; Jimenez Mutiloa, E18; Macedo, G19; Maida, I; Ryan, P21; Campanale, F22; Bascia, A23; Conway, B24; Ranieri, R25; Borgia, S26; De Lédinghen, V27; Mangia, A28; Mertens, M29; Vanstraelen, K29; Ntalla, I30; Hernandez-Lopez, C29; Di Marco, V31. - In: HEPATOLOGY. - ISSN 0270-9139. - (2020).
EFFECTIVENESS OF SOFOSBUVIR/VELPATASVIR (SOF/VEL) IN PATIENTS WITH CHRONIC HCV INFECTION AND PSYCHIATRIC DISORDERS: REAL-WORLD CARE MANAGEMENT FROM 6 COUNTRIES
Maida I
;
2020-01-01
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
